Literature DB >> 17578770

Systemic inflammation in patients with chronic obstructive pulmonary disease who are colonized with Pneumocystis jiroveci.

Enrique J Calderón1, Laura Rivero, Nieves Respaldiza, Rubén Morilla, Marco A Montes-Cano, Vicente Friaza, Fernando Muñoz-Lobato, José M Varela, Francisco J Medrano, Carmen de la Horra.   

Abstract

In chronic obstructive pulmonary disease, high levels of airway and systemic inflammatory markers are associated with a faster decrease in lung function. Our study shows that patients colonized by Pneumocystis jiroveci have higher proinflammatory cytokine levels than do noncolonized patients. This suggests that Pneumocystis may play a role in disease progression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17578770     DOI: 10.1086/518989

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  37 in total

Review 1.  Fungal Pathogens in CF Airways: Leave or Treat?

Authors:  A Singh; A Ralhan; C Schwarz; D Hartl; A Hector
Journal:  Mycopathologia       Date:  2017-08-02       Impact factor: 2.574

2.  Persistent pneumocystis colonization leads to the development of chronic obstructive pulmonary disease in a nonhuman primate model of AIDS.

Authors:  Timothy W Shipley; Heather M Kling; Alison Morris; Sangita Patil; Jan Kristoff; Siobhan E Guyach; Jessica E Murphy; Xiuping Shao; Frank C Sciurba; Robert M Rogers; Thomas Richards; Paul Thompson; Ronald C Montelaro; Harvey O Coxson; James C Hogg; Karen A Norris
Journal:  J Infect Dis       Date:  2010-07-15       Impact factor: 5.226

3.  Experimental Pneumocystis lung infection promotes M2a alveolar macrophage-derived MMP12 production.

Authors:  Michael P Nelson; Benjamin S Christmann; Chad W Dunaway; Alison Morris; Chad Steele
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-07-06       Impact factor: 5.464

Review 4.  Respiratory Mycoses in COPD and Bronchiectasis.

Authors:  Pei Yee Tiew; Micheál Mac Aogáin; Soo Kai Ter; Stefano Aliberti; James D Chalmers; Sanjay H Chotirmall
Journal:  Mycopathologia       Date:  2021-03-11       Impact factor: 2.574

5.  B cells modulate systemic responses to Pneumocystis murina lung infection and protect on-demand hematopoiesis via T cell-independent innate mechanisms when type I interferon signaling is absent.

Authors:  Teri R Hoyt; Erin Dobrinen; Irina Kochetkova; Nicole Meissner
Journal:  Infect Immun       Date:  2014-12-01       Impact factor: 3.441

6.  Decreased serum antibody responses to recombinant pneumocystis antigens in HIV-infected and uninfected current smokers.

Authors:  Kristina Crothers; Kieran R Daly; David Rimland; Matthew Bidwell Goetz; Cynthia L Gibert; Adeel A Butt; Amy C Justice; Kpandja Djawe; Linda Levin; Peter D Walzer
Journal:  Clin Vaccine Immunol       Date:  2010-12-29

7.  Distribution of Pneumocystis jirovecii in lungs from colonized COPD patients.

Authors:  Sheila Sivam; Frank C Sciurba; Lorrie A Lucht; Yingze Zhang; Steven R Duncan; Karen A Norris; Alison Morris
Journal:  Diagn Microbiol Infect Dis       Date:  2011-09       Impact factor: 2.803

8.  Prospective multicenter study of Pneumocystis jirovecii colonization among cystic fibrosis patients in France.

Authors:  Francisca Hernández-Hernández; Emilie Fréalle; Patrick Caneiro; Julia Salleron; Isabelle Durand-Joly; Isabelle Accoceberry; Jean-Philippe Bouchara; Benoit Wallaert; Eduardo Dei-Cas; Laurence Delhaes
Journal:  J Clin Microbiol       Date:  2012-09-26       Impact factor: 5.948

9.  Pneumocystis murina infection and cigarette smoke exposure interact to cause increased organism burden, development of airspace enlargement, and pulmonary inflammation in mice.

Authors:  Paul J Christensen; Angela M Preston; Tony Ling; Ming Du; W Bradley Fields; Jeffrey L Curtis; James M Beck
Journal:  Infect Immun       Date:  2008-05-19       Impact factor: 3.441

10.  Serum markers in interstitial pneumonia with and without Pneumocystis jirovecii colonization: a prospective study.

Authors:  Yasuo Shimizu; Noriaki Sunaga; Kunio Dobashi; Makoto Fueki; Naoto Fueki; Sohei Makino; Masatomo Mori
Journal:  BMC Infect Dis       Date:  2009-04-22       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.